# FibroBiologics, Inc.: filings

FBLG · Nasdaq · CIK 1958777 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fblg.md) · [Financials](/companies/fblg/financials.md) · [Filings](/companies/fblg/filings.md) · [Insiders](/companies/fblg/insiders.md)

## Reports and events: 87 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 46, 4 37, CORRESP 14, S-1/A 13, 3 12, EFFECT 12, UPLOAD 10, 10-Q 8, 3/A 8, S-1 7, D 6, DEF 14A 6, 424B4 5, 424B5 5, DEFA14A 5, PRE 14A 5, DRS 4, POS AM 4, SCHEDULE 13G 4, 10-K 3, ARS 3, 424B3 2, 8-K/A 2, C/A 2, DRS/A 2, DRSLTR 2, S-3 2, 10-K/A 1, 8-A12B 1, C 1, C-AR 1, CERT 1, C-U 1, FWP 1, RW 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 21:15 ET | [8-K](/filings/0001193125-26-418065.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-418065 |
| 2026-09-18 | 20:05 ET | [8-K](/filings/0001193125-26-395511.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-395511 |
| 2026-09-17 | 20:01 ET | [SCHEDULE 13D](/filings/0001493152-26-043112.md) | Ownership report, active investor | 0001493152-26-043112 |
| 2026-09-15 | 11:15 ET | [8-K](/filings/0001193125-26-391310.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-391310 |
| 2026-08-24 | 12:48 ET | [8-K](/filings/0001193125-26-362027.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-362027 |
| 2026-07-31 | 20:04 ET | [10-Q](/filings/0001193125-26-328454.md) | Quarterly report, period 2026-06-30 | 0001193125-26-328454 |
| 2026-07-31 | 13:14 ET | [DEF 14A](/filings/0001193125-26-326818.md) | Proxy statement, period 2026-09-17 | 0001193125-26-326818 |
| 2026-07-24 | 20:05 ET | [8-K](/filings/0001193125-26-316067.md) | 3.01 Delisting notice | 0001193125-26-316067 |
| 2026-07-09 | 13:31 ET | [8-K](/filings/0001193125-26-299290.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-299290 |
| 2026-06-29 | 20:15 ET | [8-K](/filings/0001193125-26-288468.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-288468 |
| 2026-06-23 | 21:16 ET | [8-K](/filings/0001193125-26-279778.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-279778 |
| 2026-05-06 | 11:02 ET | [8-K](/filings/0001193125-26-207530.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-207530 |
| 2026-05-05 | 11:21 ET | [8-K](/filings/0001193125-26-205044.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-205044 |
| 2026-05-05 | 11:18 ET | [DEF 14A](/filings/0001193125-26-205032.md) | Proxy statement, period 2026-05-05 | 0001193125-26-205032 |
| 2026-05-01 | 20:01 ET | [8-K](/filings/0001193125-26-201376.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-201376 |
| 2026-04-30 | 21:19 ET | [10-Q](/filings/0001193125-26-197858.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197858 |
| 2026-04-20 | 20:15 ET | [8-K](/filings/0001193125-26-164018.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164018 |
| 2026-04-17 | 20:05 ET | [8-K](/filings/0001193125-26-161507.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-161507 |
| 2026-04-09 | 21:20 ET | [8-K/A](/filings/0001193125-26-149865.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149865 |
| 2026-04-09 | 20:15 ET | [8-K](/filings/0001193125-26-149654.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149654 |
| 2026-04-03 | 20:02 ET | [8-K](/filings/0001193125-26-142089.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-142089 |
| 2026-04-02 | 20:03 ET | [8-K](/filings/0001193125-26-140044.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-140044 |
| 2026-03-27 | 21:19 ET | [S-1](/filings/0001493152-26-013274.md) | Registration statement | 0001493152-26-013274 |
| 2026-03-13 | 20:20 ET | [10-K/A](/filings/0001193125-26-106216.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-106216 |
| 2026-03-06 | 21:03 ET | [8-K](/filings/0001193125-26-096474.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-096474 |
| 2026-02-24 | 21:06 ET | [10-K](/filings/0001193125-26-066965.md) | Annual report, period 2025-12-31 | 0001193125-26-066965 |
| 2026-02-23 | 21:18 ET | [8-K](/filings/0001193125-26-064040.md) | 5.07 Shareholder vote results | 0001193125-26-064040 |
| 2026-02-06 | 21:10 ET | [8-K](/filings/0001193125-26-041187.md) | 3.01 Delisting notice | 0001193125-26-041187 |
| 2026-01-02 | 22:15 ET | [8-K](/filings/0001193125-26-001077.md) | 3.01 Delisting notice | 0001193125-26-001077 |
| 2025-12-29 | 14:31 ET | [DEF 14A](/filings/0001193125-25-332248.md) | Proxy statement, period 2026-02-20 | 0001193125-25-332248 |
| 2025-12-23 | 21:02 ET | [S-1](/filings/0001493152-25-029010.md) | Registration statement | 0001493152-25-029010 |
| 2025-12-18 | 11:37 ET | [DEF 14A](/filings/0001193125-25-323667.md) | Proxy statement, period 2025-12-18 | 0001193125-25-323667 |
| 2025-12-15 | 22:22 ET | [8-K](/filings/0001193125-25-319441.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-25-319441 |
| 2025-11-25 | 13:31 ET | [8-K](/filings/0001193125-25-294634.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-25-294634 |
| 2025-11-19 | 21:53 ET | [8-K](/filings/0001193125-25-288264.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-288264 |
| 2025-10-31 | 20:05 ET | [10-Q](/filings/0001193125-25-260774.md) | Quarterly report, period 2025-09-30 | 0001193125-25-260774 |
| 2025-08-08 | 20:05 ET | [8-K](/filings/0000950170-25-105807.md) | 3.01 Delisting notice | 0000950170-25-105807 |
| 2025-07-31 | 20:15 ET | [10-Q](/filings/0000950170-25-100917.md) | Quarterly report, period 2025-06-30 | 0000950170-25-100917 |
| 2025-07-18 | 20:08 ET | [8-K/A](/filings/0000950170-25-096923.md) | 3.02 Unregistered sale of equity | 0000950170-25-096923 |
| 2025-07-18 | 20:05 ET | [8-K](/filings/0000950170-25-096914.md) | 3.02 Unregistered sale of equity | 0000950170-25-096914 |
| 2025-07-03 | 20:03 ET | [8-K](/filings/0000950170-25-093832.md) | 3.01 Delisting notice | 0000950170-25-093832 |
| 2025-06-16 | 21:00 ET | [8-K](/filings/0001641172-25-015282.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015282 |
| 2025-06-13 | 20:00 ET | [8-K](/filings/0001641172-25-015065.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015065 |
| 2025-06-09 | 20:01 ET | [8-K](/filings/0001641172-25-014296.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014296 |
| 2025-05-14 | 20:01 ET | [10-Q](/filings/0001641172-25-010252.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010252 |
| 2025-05-05 | 20:01 ET | [8-K](/filings/0001641172-25-008680.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-008680 |
| 2025-04-23 | 10:01 ET | [DEF 14A](/filings/0001641172-25-005760.md) | Proxy statement, period 2024-12-31 | 0001641172-25-005760 |
| 2025-03-31 | 20:04 ET | [10-K](/filings/0001641172-25-001691.md) | Annual report, period 2024-12-31 | 0001641172-25-001691 |
| 2025-02-07 | 22:24 ET | [8-K](/filings/0001493152-25-005456.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-005456 |
| 2025-01-24 | 21:05 ET | [8-K](/filings/0001493152-25-003571.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-003571 |

Page 1 of 2. [Older](/companies/fblg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.